Routine terminations of pregnancy--should we screen for gestational trophoblastic neoplasia?

Seckl, Michael J; Gillmore, Roopinder; Foskett, Marianne; Sebire, Neil J; Rees, Helene; Newlands, Edward S · Lancet

retrospective_cohort · Level III

Where this comes from

Abstract

After termination of pregnancy for non-medical reasons, the products of conception are often not routinely examined for gestational trophoblastic neoplasia. Between 1995 and 2001 we identified 15 women without and 36 women with a pathological diagnosis of gestational trophoblastic neoplasia at the time of their pregnancy termination. Women without a diagnosis were significantly more likely to have subsequent life-threatening complications of gestational trophoblastic neoplasia (four of 15 vs none of 36; p=0.003), and to require surgical intervention (15 of 15 vs one of 36; p<0.0001) and chemotherapy (nine of 15 vs two of 36; p<0.0001). All women should be screened for gestational trophoblastic neoplasia after termination of pregnancy.

Medical subject headings